Home›Daridorexant›Daridorexant + Cyp3a Inducers

Does Daridorexant Interact with Cyp3a Inducers?

Daridorexant and Cyp3a Inducers have a contraindicated drug interaction according to U.S. FDA drug labeling data. Concomitant use with strong CYP3A4 inducers decreases daridorexant exposure and may reduce efficacy. Concomitant use is not recommended. The mechanism involves cyp3a4 induction decreases daridorexant exposure. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.

Severity
Contraindicated
Daridorexant Class
Orexin Receptor Antagonist
Management
Do not take together
Data Source
U.S. FDA via OpenFDA

How This Interaction Works

The interaction between Daridorexant and Cyp3a Inducers occurs because cyp3a4 induction decreases daridorexant exposure. Clinically, this means concomitant use with strong cyp3a4 inducers decreases daridorexant exposure and may reduce efficacy. concomitant use is not recommended. Because of the severity of this interaction, these medications are contraindicated — meaning they should not be taken together under any circumstances. If you are currently taking both, contact your healthcare provider immediately to discuss alternatives.

What To Tell Your Doctor or Pharmacist

If you are taking Daridorexant and your doctor is considering prescribing Cyp3a Inducers (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Ask about alternative medications that do not interact with your current regimen
  • Ask how frequently you should be monitored while these are co-prescribed
  • Never stop or change either medication without first consulting your healthcare provider
💊 Daridorexant(Quviviq)+💊 Cyp3a Inducers

Severity & Interaction Details

⛔
contraindicated
Avoid this combination
FDA labeling lists this pair as contraindicated. The risk outweighs the benefit in nearly all cases.
Severity scale
MinorContra
On record
Yes
Drug A class
Orexin Receptor Antagonist
Drug B class
—
Source
NLP:daridorexant

What this means in plain English

Concomitant use with strong CYP3A4 inducers decreases daridorexant exposure and may reduce efficacy. Concomitant use is not recommended.

About Daridorexant and Cyp3a Inducers

Daridorexant is an Orexin Receptor Antagonist. Daridorexant is also sold under the brand name Quviviq. Daridorexant is taken by mouth.

What the FDA label says

"CYP3A4 induction decreases daridorexant exposure"

📖 Source: NLP:daridorexant

Share this result:

WhatsAppText / SMSEmail
Also share on:XFacebook
Add more drugs
Check Daridorexant and Cyp3a Inducers against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →
Data integrity: Every interaction shown is extracted directly from official U.S. FDA drug labeling via openFDA and the U.S. National Library of Medicine (NIH) — no interactions are invented, inferred, or manually edited. Maintained by CheckDrugInteractions.com. See our methodology or report a correction at support@checkdruginteractions.com.

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine, supplemented with a small number of well-established interactions from curated clinical references. For informational purposes only. Always consult your pharmacist or physician.